The Happy PharmD

SEPTEMBER 15, 2024

Well, now’s the perfect time to dive into a discussion with me about the latest insights from the 2023 report by the Well-Being Index. Watch this discussion on YouTube: 2023 Well-Being Report: Are Pharmacist Stress Levels Being Downplayed? Or perhaps it’s the constant back-and-forth with insurance companies over coverage?

Insurance Coverage and Processing 52

Insurance Coverage and Processing Dosage Documentation Communication 52

ID Stewardship

JUNE 6, 2023

BCPS, BCIDP Article Posted 7 June 2023 With the exception of the questions in bold, this entire text was written by ChatGPT. We’ll dive into the many ways AI can assist pharmacists, from streamlining medication dispensing processes to enhancing patient education. Interview with: ChatGPT by OpenAI Interview by: Timothy P.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Prescription Filling Hospitals Medication Dispensing 52

The Thyroid Pharmacist

AUGUST 4, 2023

4] One of the key things to note is that this gene variation also prevents people from properly methylating, which is one of the body’s key detox processes that helps them get rid of toxins. However, some may be concerned with this genetic information getting reported on insurance or to employers.

Insurance Coverage and Processing 105

Insurance Coverage and Processing Immunity Immunization Dosage 105

The Thyroid Pharmacist

JUNE 30, 2023

Many times, people have been able to eliminate their symptoms and reduce their dosages of medications. Luckily, even without insurance coverage, this medication is available in generic form and is very affordable, usually costing between $15 to $40 per month. It’s a process and a journey, but it’s definitely worth it.

Compounding 98

Compounding Immunity Immunization Compounding Pharmacies 98

PharmaShots

MAY 24, 2023

The report is concluded with an engaging SWOT analysis and edifying KOL reviews Active Ingredient: (elexacaftor, tezacaftor, and ivacaftor tablets, ivacaftor tablets) Dosage Forms & Strengths: Tablets: fixed-dose combination containing elexacaftor 100 mg, tezacaftor 50 mg, and ivacaftor 75 mg. In Apr 2023, Vertex announced the U.S.

Insurance Coverage and Processing 56

Insurance Coverage and Processing Hospitals Dosage Pharmaceutical Companies 56

PharmaShots

JUNE 28, 2023

PharmaShots' analysis of Enbrel’s industry trials is depicted below: (Trials were taken on 6 Jun 2023). The chart depicts data till 8th Jun 2023). Plaque Psoriasis (Moderate to Severe): The drug is used for children aged 4≥yrs and adults Clinical Trials Analysis3 Currently, Enbrel is undergoing 541 trials, incl.

Biosimilars 40

Biosimilars Insurance Coverage and Processing Dosage Compounding 40